Your central resource for PET educational materials, including evidence-based publications, clinical case studies, and product resources. Check out the new SOFIE Education Hub Go to the education hub

With our premier radiopharmacy network, mature contract manufacturing services and high value theranostic intellectual property, SOFIE is dedicated to improving patient health.

Our team works alongside our Pharma and Academic partners to revolutionize clinical diagnostics and therapeutics to better understand and treat the biology of disease.

Transparency in Coverage (TiC) regulations requires health insurers and group Health Plans to post their provider link on company websites. View SOFIE’s Link here View our Privacy Policy

SOFIE has built a high-capacity PET radiopharmaceutical network capable of delivering large volumes of products to as many patients as possible. Our product lines include FDG, Pylarify, Neuraceq, and …

In Nov 2019, SOFIE Biosciences (SOFIE) licensed quinoline-based PET tracers, developed by the team at Heidelberg University, that act as FAP inhibitors (FAPI) and showed promising clinical data in a …

SOFIE is dedicated to providing reliable, high quality radiopharmaceuticals and cutting-edge technologies

GE HealthCare and SOFIE Biosciences (SOFIE) announced a partnership to develop, manufacture and commercialize SOFIE’s Gallium-68 and Fluorine-18 labelled diagnostics targeting fibroblast …

Oct 1, 2025 · With its robust radiopharmaceutical production and distribution network, mature contract manufacturing services, and now, high-value theranostic intellectual property, SOFIE is poised to …

SOFIE 21000 Atlantic Blvd., Ste 730 Dulles, VA 20166 Phone: +1 703 787 7900 For general inquiries: [email protected] For FAPI-related inquiries: [email protected]